Cargando…
Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma
As one of the most common types of renal cancer, clear cell renal cell carcinoma (ccRCC) in advanced stages constitutes a continued major challenge for uro-oncologists, as the identification of novel driver mutations and the development of novel targeted therapies against them remain an unmet need....
Autores principales: | Chen, Wei, Li, Wei, Bai, Bing, Wei, Huafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041106/ https://www.ncbi.nlm.nih.gov/pubmed/32020234 http://dx.doi.org/10.3892/or.2020.7462 |
Ejemplares similares
-
A primary retroperitoneal anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor thrombosis
por: Li, Jisong, et al.
Publicado: (2018) -
Primary gastric anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma
por: Tian, Chen, et al.
Publicado: (2016) -
Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma
por: Ning, Hanna, et al.
Publicado: (2013) -
Integrated Analysis of the Role of Enolase 2 in Clear Cell Renal Cell Carcinoma
por: Pan, Jiaren, et al.
Publicado: (2022) -
The Usefulness of Straight Chemotherapy for Dermal Exposed Anaplastic Lymphoma Kinase Fusion-Positive Anaplastic Large-Cell Lymphoma with Intracranial Invasion
por: Abe, Hiroyuki, et al.
Publicado: (2019)